Fareston 60 MG Oral Tablet

RxCUI: 152880
RxNorm name: Fareston 60 MG Oral Tablet
Display name: Fareston 60 MG Oral Tablet
Full name: Fareston 60 MG Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:52

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Fareston	TOREMIFENE CITRATE	Kyowa Kirin, Inc.	2cab8dd1-3a10-48e6-86ce-0e5275ed49e5	2024-11-13	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 152880

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
2cab8dd1-3a10-48e6-86ce-0e5275ed49e5	Fareston 60 MG Oral Tablet	SY	11	These highlights do not include all the information needed to use FARESTON® safely and effectively. See full prescribing information for FARESTON®. FARESTON® (toremifene citrate) 60 mg Tablets oral administration Initial U.S. Approval: 1997	20241113
2cab8dd1-3a10-48e6-86ce-0e5275ed49e5	toremifene 60 MG Oral Tablet [Fareston]	SBD	11	These highlights do not include all the information needed to use FARESTON® safely and effectively. See full prescribing information for FARESTON®. FARESTON® (toremifene citrate) 60 mg Tablets oral administration Initial U.S. Approval: 1997	20241113
2cab8dd1-3a10-48e6-86ce-0e5275ed49e5	Fareston GTx 60 MG Oral Tablet	PSN	11	These highlights do not include all the information needed to use FARESTON® safely and effectively. See full prescribing information for FARESTON®. FARESTON® (toremifene citrate) 60 mg Tablets oral administration Initial U.S. Approval: 1997	20241113